De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus

被引：0
|
作者：
Capranzano, Piera [1 ]
Angiolillo, Dominick J. [2 ]
机构：
[1] Univ Catania, Div Cardiol, CAST Policlin Hosp, Via S Sofia 78, I-95123 Catania, Italy
[2] Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA
来源：
EUROINTERVENTION | 2019年 / 15卷 / 06期
关键词：
ACUTE CORONARY SYNDROME; TROPICAL-ACS; ANTIPLATELET TREATMENT; FUNCTION PROFILES; ARTERY-DISEASE; CLOPIDOGREL; OUTCOMES; THERAPY; INTERVENTION; GUIDELINES;
D O I：
10.4244/EIJV15I6A89
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E486 / E489
页数：4
相关论文
共 50 条
  • [41] Comparison of the effects of P2Y12 receptor antagonists on platelet function in patients undergoing primary PCI: a substudy of the HEAT-PPCI trial
    Shahzad, Adeel
    Khanna, Vikram
    Kemp, Ian
    Shaw, Matthew
    Mars, Christine
    Cooper, Robert
    Wilson, Keith
    Curzen, Nick
    Stables, Rod H.
    EUROINTERVENTION, 2018, 13 (16) : 1931 - 1938
  • [42] Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors
    Kubica, Jacek
    Kubica, Aldona
    Jilma, Bernd
    Adamski, Piotr
    Hobl, Eva-Luise
    Navarese, Eliano Pio
    Siller-Matula, Jolanta Maria
    Dabrowska, Anita
    Fabiszak, Tomasz
    Kozinski, Marek
    Gurbel, Paul Alfred
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 215 : 201 - 208
  • [43] De-escalation of P2Y12 Inhibitor Use After Percutaneous Coronary Intervention and Acute Coronary Syndromes
    Barry, Quinton
    Fu, Angel
    Boudreau, Rene
    Chow, Alyssa
    Clifford, Cole
    Simard, Trevor
    Chong, Aun Yeong
    Dick, Alexander
    Froeschl, Michael
    Glover, Christopher
    Hibbert, Benjamin
    Labinaz, Marino
    Le May, Michel
    Russo, Juan
    So, Derek
    CJC OPEN, 2021, 3 (09) : 1091 - 1099
  • [44] Efficacy and Safety of Potent Oral P2Y12 Inhibitors in Medically Managed ACS Patients: a Meta-analysis
    Ma, Sicong
    Li, Zhiguo
    Yu, Peng
    Song, Haixu
    Jiang, Zaixin
    Li, Yi
    Han, Yaling
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (02) : 199 - 208
  • [45] Efficacy and Safety of Potent Oral P2Y12 Inhibitors in Medically Managed ACS Patients: a Meta-analysis
    Sicong Ma
    Zhiguo Li
    Peng Yu
    Haixu Song
    Zaixin Jiang
    Yi Li
    Yaling Han
    Cardiovascular Drugs and Therapy, 2020, 34 : 199 - 208
  • [46] Comparing loading strategies of P2Y12 inhibitors in patients undergoing elective PCI: a network meta-analysis
    Gupta, R.
    Malik, A.
    Vadhar, S.
    Briasoulis, A.
    Vyas, A.
    Patel, N.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1210 - 1210
  • [47] Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitors
    Thomas, Mark R.
    Storey, Robert F.
    VASCULAR PHARMACOLOGY, 2016, 84 : 25 - 27
  • [48] Platelets Express Activated P2Y12 Receptor in Patients With Diabetes Mellitus
    Hu, Liang
    Chang, Lin
    Zhang, Yan
    Zhai, Lili
    Zhang, Shenghui
    Qi, Zhiyong
    Yan, Hongmei
    Yan, Yan
    Luo, Xinping
    Zhang, Si
    Wang, Yiping
    Kunapuli, Satya P.
    Ye, Hongying
    Ding, Zhongren
    CIRCULATION, 2017, 136 (09) : 817 - U102
  • [49] EFFECTS OF PIOGLITAZONE ON PLATELET P2Y12 MEDIATED SIGNALING IN CLOPIDOGREL TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Suryadevara, Siva
    Ueno, Masafumi
    Tello-Montoliu, Antonio
    Ferreiro, Jose Luis
    Desai, Bhaloo
    Rollini, Fabiana
    Box, Lyndon
    Zenni, Martin
    Guzman, Luis
    Bass, Theodore
    Angiolillo, Dominick
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E263 - E263
  • [50] Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in PCI
    Pauley, Eric D.
    Doorey, Andrew J.
    Stouffer, George A.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (18) : 1867 - 1867
12345